Beacon Pointe Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Beacon Pointe Wealth Advisors's LLY Position: Q4 2019 in Review
Beacon Pointe Wealth Advisors increased its Eli Lilly (LLY) stake by 6.2% in Q4 2019, buying an estimated $15.3K and bringing the position to 2,252 shares worth $297K. The position accounts for 0.05% of the portfolio, ranked #218.
Beacon Pointe Wealth Advisors first reported a position in LLY in Q4 2018 and has held it in 5 quarters since. The position peaked at $718K in Q1 2019. 1,672 funds tracked by Wall St. Rank hold LLY as of Q4 2019.
- Beacon Pointe Wealth Advisors held 2,252 shares of Eli Lilly worth $297K as of Q4 2019.
- Beacon Pointe Wealth Advisors bought 132 Eli Lilly shares in Q4 2019, an estimated $15.3K.
- Eli Lilly made up 0.05% of Beacon Pointe Wealth Advisors's portfolio in Q4 2019, its #218 holding.
- Beacon Pointe Wealth Advisors first reported a position in Eli Lilly in Q4 2018 and has held it in 5 quarters since.
- Beacon Pointe Wealth Advisors's Eli Lilly position peaked at $718K in Q1 2019.
- 1,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2019.
Based on Beacon Pointe Wealth Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.